Circulating SMRP and CA ‐125 before and after pleurectomy decortication for pleural mesothelioma
Thoracic Cancer · 2024
DOI: 10.1111/1759-7714.15264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, 2024. Verfasst von Juuso Paajanen und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Thoracic Surgery Oncology Laboratory and the International Mesothelioma Program (http://www.impmeso.org), Division of Thoracic Surgery and the Lu…. Hauptthemen laut MEDLINE: CA-125 Antigen, Pleural Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MedGenome, Serum intuitive, Siemens.
Abstract (Originalsprache)
Background
Tumor recurrence remains the main barrier to survival after surgery for pleural mesothelioma (PM). Soluble mesothelin‐related protein (SMRP) and cancer antigen 125 (CA‐125) are established blood‐based biomarkers for monitoring PM. We prospectively studied the utility of these biomarkers after pleurectomy decortication (PD).
Methods
Patients who underwent PD and achieved complete macroscopic resection with available preoperative SMRP levels were included. Tumor marker levels were determined within 60 days of three timepoints: (1) preoperation, (2) post‐operation, and (3) recurrence.
Results
Of 356 evaluable patients, 276 (78%) had recurrence by the end of follow‐up interval. Elevated preoperative SMRP levels were associated with epithelioid histology ( p < 0.013), advanced TNM ( p < 0.001) stage, and clinical stage ( p < 0.001). Preoperative CA‐125 levels were not significantly associated with clinical covariates. Neither biomarker was associated with survival or disease‐free survival. With respect to nonpleural and nonlymphatic recurrences, mean SMRP levels were elevated in patients with pleural ( p = 0.021) and lymph node ( p = 0.042) recurrences. CA‐125 levels were significantly higher in patients with abdominal ( p < 0.001) and lymph node ( p = 0.004) recurrences. Among patients with all three timepoints available, we observed an average decrease in SMRP levels by 1.93 nmol/L ( p < 0.001) postoperatively and again an average increase at recurrence by 0.79 nmol/L ( p < 0.001). There were no significant changes in levels of CA‐125 across the study timepoints ( p = 0.47).
Conclusions
Longitudinal changes in SMRP levels corresponded with a radiographic presence of disease in a subset of patients. SMRP surveillance could aid in detection of local recurrences, whereas CA‐125 could be helpful in recognizing abdominal recurrences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Thoracic Surgery Oncology Laboratory and the International Mesothelioma Program (http://www.impmeso.org), Division of Thoracic Surgery and the Lung Center, Brigham, and Women's Hospital, Harvard Medical School, Bost…
- Deparment of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
- Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Juuso Paajanen
Förderung
- MedGenome
- Serum intuitive
- Siemens
- Merck
- Genentech Foundation
- Roche
- Bicycles therapeutics
- Verastem Oncology
Zitieren
APA
Paajanen, J., Sadek, A., Richards, W. G., Xie, Y., Mazzola, E., Sidopoulos, K., Kuckelman, J., Gill, R. R., & Bueno, R. (2024). Circulating SMRP and CA ‐125 before and after pleurectomy decortication for pleural mesothelioma. Thoracic Cancer. https://doi.org/10.1111/1759-7714.15264
Vancouver
Paajanen J, Sadek A, Richards WG, Xie Y, Mazzola E, Sidopoulos K, et al. Circulating SMRP and CA ‐125 before and after pleurectomy decortication for pleural mesothelioma. Thoracic Cancer. 2024. doi:10.1111/1759-7714.15264
BibTeX
@article{Paajanen2024,
author = {Paajanen, Juuso and Sadek, Ahmed and Richards, William G and Xie, Yue and Mazzola, Emanuele and Sidopoulos, Kristina and Kuckelman, John and Gill, Ritu R and Bueno, Raphael},
title = {Circulating SMRP and CA ‐125 before and after pleurectomy decortication for pleural mesothelioma},
journal = {Thoracic Cancer},
year = {2024},
doi = {10.1111/1759-7714.15264}
}
EUVIMED